KAYANN WILSON: Open Payments
NPI 1952371908 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,224 in 111 payments from 22 companies in 2025. Trend: 2023 $775 · 2024 $1,353 · 2025 $2,224
Food & beverage: $2,224
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $583 |
| ARGENX US, INC. | 7 | $227 |
| UCB, Inc. | 6 | $203 |
| Alexion Pharmaceuticals, Inc. | 10 | $195 |
| SK Life Science, Inc. | 7 | $153 |
| Otsuka America Pharmaceutical, Inc. | 6 | $142 |
| Lilly USA, LLC | 6 | $122 |
| Axsome Therapeutics, Inc. | 3 | $93 |
| Eisai Inc. | 4 | $82 |
| Merz Pharmaceuticals, LLC | 2 | $62 |
Products named: QULIPTA, VYVGART HYTRULO, Rystiggo, ULTOMIRIS, UBRELVY, REXULTI, KISUNLA, Symbravo.
Industry payments across NY — which companies pay providers there.
